Prediction: Warren Buffett's Successor, Greg Abel, Will Dispose of One of Berkshire Hathaway's Largest Holdings

Berkshire Hathaway has sold nearly 549.5 million Bank of America shares since June 30, 2024, reducing its stake by 53%, and the article argues Greg Abel may fully exit the position. BofA traded at a 59% premium to book value as of Sept. 11, versus a 62% discount when Berkshire made its original 2011 investment, weakening its value appeal. The bank's outsized interest-rate sensitivity has also become a headwind after six Fed rate cuts between September 2024 and December 2025.

Analysis

The relevant incremental risk to BAC is not a binary exit but a renewed, price-insensitive institutional supply overhang at a time when its multiple already embeds a normalization in returns. A further reduction would likely pressure BAC disproportionately around 13F/quarterly disclosure windows, even if the underlying franchise is unchanged; passive holders and Buffett-following investors can amplify that flow. The impact should be measured against BAC’s average daily dollar volume and Berkshire’s residual position, neither of which is supplied here, before treating this as a directional catalyst.

Fundamentally, BAC remains the large-cap bank with the greatest earnings sensitivity to the path of short rates, but the more important variable is the combined curve/loan-growth outcome. A steepening curve and renewed commercial-loan growth can offset lower policy rates through deposit repricing and asset yields; a rapid easing cycle paired with soft credit demand instead creates negative operating leverage. Over the next 1-3 months, disclosure-driven positioning is the catalyst; over 6-18 months, ROTCE versus its cost of equity—not book-value optics alone—will determine whether a premium multiple is defensible.

The contrarian case is that the selling signal is stale: a large portion of the potential supply has already been distributed, while BAC’s valuation premium may reflect structurally improved capital returns, deposit franchise quality, and a less punitive regulatory outcome. The thesis is falsified if BAC delivers accelerating net interest income despite lower rates, maintains benign net charge-offs, and guides capital return higher; conversely, a meaningful NII-guide cut or rising office/consumer credit costs would make the relative short more compelling.

Key Decisions for Investors

• Initiate a 1-3 month tactical pair: short BAC / long JPM in equal beta-weighted dollars. JPM offers greater fee-income and scale diversification, while BAC has higher downside sensitivity if easing and incremental shareholder supply coincide. Target 5-8% relative downside; stop if BAC outperforms JPM by 5% following earnings or BAC raises NII guidance.
• Do not short BAC solely ahead of a presumed Berkshire filing. Set an alert once confirmed residual ownership, expected selling cadence, and BAC average daily volume establish that a plausible quarterly sale exceeds roughly 3-5 trading days of normal volume.
• For defined-risk bearish exposure, consider BAC put spreads 3-6 months out only after a break below post-earnings support or a negative NII revision. Avoid naked puts: curve steepening, buyback authorization, or an end to Berkshire sales can produce a sharp relief rally.
• Maintain BRK.B as a separate governance/portfolio-construction watch rather than a trade on this development. A smaller BAC concentration marginally lowers portfolio financial-sector beta, but it does not by itself alter Berkshire’s operating earnings or valuation framework.